Company / PP&E (Net)
Phio Pharmaceuticals Corp. PP&E (Net) History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$157.0K
FY2020
5-year range
$114.0K / $248.0K
FY2016-FY2020
Trend
-25.2%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has fluctuated over the past 7 years, ranging from $114,000 in FY2016 to $248,000 in FY2017.
Based on SEC 10-K filings.
$157,000 in FY2020 with a 3-year CAGR of -14.1%.
Declined from $172,000 to $157,000 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -14.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -14.1%, indicating a declining trend.
- In FY2020, pp&e (net) decreased 25.2% year-over-year.
- Peak pp&e (net) was recorded in FY2017.
- Lowest pp&e (net) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2020 | $157.0K | -25.2% |
| FY2019 | $210.0K | +22.1% |
| FY2018 | $172.0K | -30.6% |
| FY2017 | $248.0K | +117.5% |
| FY2016 | $114.0K | -35.6% |
| FY2013 | $177.0K | -10.6% |
| FY2012 | $198.0K | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026